Diagnostic assay utilizing recombinant antibody technology to evaluate prostate cancer risk and aggressiveness from non-invasive urine samples. Designed for simplicity of operation and cost-effective accessibility in resource-limited settings.
Manufactured by
iPASY Technologies Kft
Veszprém, Hungary
iPASy is revolutionizing prostate cancer screening with a urine-based, non-invasive diagnostic that detects disease-specific glycan patterns of urinary PSA, offering up to six-times higher specificity than blood-based tests. Our vision is to make prostate cancer detection accurate, accessible, and patient-friendly worldwide , with upcoming launches in Europe and the U.S. in collaboration with Mayo Clinic .
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Intelligenome
United States · 1 relevant product
AVE Science & Technology Co.,Ltd.
China · 2 relevant products
Sclavo Diagnostics International S.p.A.
Italy · 2 relevant products
72 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →14 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 93 closest product alternatives
Intelligenome · United States
CRISPR-based diagnostic assay for oncology applications. Provides molecular detection and monitoring capabilities for cancer-related diagnostics.
AVE Science & Technology Co.,Ltd. · China
Reagent system for measuring tumor-associated antigens in patient samples. Supports cancer screening and treatment monitoring.
Sclavo Diagnostics International S.p.A. · Italy
Immunochemical systems for measurement of tumor-associated antigens including PSA, CEA, and AFP. Applied in cancer screening and monitoring applications.
90 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products